White Knight: Anyone who my White Knight scenario is not possible needs to look deeper: Regeneron is in the Oncology field. Regeneron is a competitor to Merck. Regeneron was once like NW Bio in terms of SP and having a platform drug. Regenerons SP was once manipulated almost to death. Kevin Duffy now works for Regeneron. I suggest everyone take a look at the recent comments from the founder of REGN in regards to immunotherapy and where REGN is heading in the future.
Market Data 
Markets 
AI
